Portal de Periódicos da CAPES

Prostaglandin E2 Production and Cyclooxygenase-2 Induction in Human Urinary Tract Infections and Bladder Cancer

2002; Lippincott Williams & Wilkins; Volume: 168; Issue: 4 Part 1 Linguagem: Inglês

10.1016/s0022-5347(05)64522-3

1527-3792

Marcia A. Wheeler, Derek A. Hausladen, Jeong Hoon Yoon, Robert M. Weiss,

Helicobacter pylori-related gastroenterology studies

No AccessJournal of UrologyINVESTIGATIVE UROLOGY1 Oct 2002Prostaglandin E2 Production and Cyclooxygenase-2 Induction in Human Urinary Tract Infections and Bladder Cancer Marcia A. Wheeler, Derek A. Hausladen, Jeong H. Yoon, and Robert M. Weiss Marcia A. WheelerMarcia A. Wheeler , Derek A. HausladenDerek A. Hausladen , Jeong H. YoonJeong H. Yoon , and Robert M. WeissRobert M. Weiss View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)64522-3AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Increased prostaglandin production correlates positively with cancer risk and cyclooxygenase (COX)-2, the inducible rate limiting enzyme for prostaglandin synthesis, is elevated in bladder cancer cases. Urinary prostaglandin levels and COX-2 expression in urine particulates may increase in urogenital cancer, including bladder cancer, and with infectious and inflammatory processes, including urinary tract infections and that resulting from bacillus Calmette-Guerin (BCG) treatment for bladder cancer. Materials and Methods: Urinary prostaglandin E2 levels were measured in patients with a urinary tract infection before and after treatment, urogenital cancer (including bladder cancer), bladder cancer in remission and bladder cancer with BCG treatment. COX-1 and COX-2 mRNA and protein were assessed in the human ureter, in normal human bladder muscle and urothelium, and in urine particulates from patients with urinary tract infections, bladder cancer and bladder cancer with BCG treatment. Results: COX-1 protein, and mRNA and COX-2 mRNA were expressed in the ureter, and bladder muscle and urothelium. Urinary prostaglandin E2 levels and COX-2 protein expression in urine particulates were elevated in patients with urinary tract infections and with bladder cancer compared with age matched controls. Successful treatment for urinary tract infections and bladder cancer lowers urinary prostaglandin E2 levels. Urinary prostaglandin E2 and COX-2 protein levels are elevated during BCG treatment. Conclusions: Increased urinary prostaglandin E2 production and COX-2 protein expression correlate with urogenital cancer, urinary tract infections and inflammatory processes, such as those induced by BCG. Patients in whom urinary tract infection was treated with antibiotics or in whom bladder cancer is in remission have reduced urinary prostaglandin E2 compared with those who have active disease. References 1 : Cyclooxygenase in biology and disease. FASEB J1998; 12: 1063. Crossref, Medline, Google Scholar 2 : Cyclooxygenase-2 protein and prostaglandin E(2) production are up regulated in a rat bladder inflammation model. Eur J Pharmacol2001; 417: 239. Crossref, Medline, Google Scholar 3 : Cyclooxygenase-2 is expressed in bladder during fetal development and stimulated by outlet obstruction. Am J Physiol1997; 273: F538. Medline, Google Scholar 4 : Prostanoids as local modulators of reflex micturition. Pharmacol Res1992; 25: 13. Crossref, Medline, Google Scholar 5 : Urinary bladder prostanoids—their synthesis, function, and possible role in the pathogenesis and treatment of disease. J Urol1987; 137: 577. Link, Google Scholar 6 : Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists. J Pharmacol Exp Ther1998; 287: 137. Medline, Google Scholar 7 : Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in rats. Br J Pharmacol2000; 130: 331. Crossref, Medline, Google Scholar 8 : Obstruction stimulates COX-2 expression in bladder smooth muscle cells via increased mechanical stretch. Am J Physiol1999; 276: F129. Medline, Google Scholar 9 : Urinary prostaglandin E2 in acute bacterial cystitis. J Urol1980; 124: 455. Link, Google Scholar 10 : Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res1999; 59: 5647. Medline, Google Scholar 11 : Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol2000; 157: 29. Crossref, Medline, Google Scholar 12 : Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. Clin Cancer Res2000; 6: 2424. Medline, Google Scholar 13 : The role of prostaglandin synthesis in prostate cancer. BJU Int2000; 85: 451. Crossref, Medline, Google Scholar 14 : Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer2000; 82: 1364. Crossref, Medline, Google Scholar 15 : Human oral neutrophils: isolation and characterization. Meth Enz1996; 268: 503. Medline, Google Scholar 16 : Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. FASEB J1998; 12: 1109. Crossref, Medline, Google Scholar 17 : Escherichia coli-induced inducible nitric oxide synthase and cyclooxygenase expression in the mouse bladder and kidney. Kidney Int2001; 59: 893. Crossref, Medline, Google Scholar 18 : Effects of ibuprofen on the in vitro invasiveness of a human transitional cell carcinoma. Anticancer Res1997; 17: 365. Medline, Google Scholar 19 : Naturally-occurring canine transitional cell carcinoma of the urinary bladder: a relevant model of human invasive bladder cancer. Urol Oncol2000; 5: 47. Crossref, Medline, Google Scholar 20 : Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Res1998; 58: 3028. Medline, Google Scholar 21 : Effect of indomethacin on N-[4-(5 nitro-2-furyl)-2-thiazolyl]formamide-induced urinary tract carcinogenesis. Carcinogenesis1995; 16: 1493. Crossref, Medline, Google Scholar From the Section of Urology, Yale University School of Medicine, New Haven, Connecticut© 2002 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited by Catalano M, Roviello G, Santi R, Villari D, Spatafora P, Galli I, Sessa F, Conte F, Mini E, Cai T and Nesi G (2023) Inflammation in Urological Malignancies: The Silent KillerInternational Journal of Molecular Sciences, 10.3390/ijms24010866, VOL. 24, NO. 1, (866) Konesan J, Liu L and Mansfield K (2022) The Clinical Trial Outcomes of Cranberry, D-Mannose and NSAIDs in the Prevention or Management of Uncomplicated Urinary Tract Infections in Women: A Systematic ReviewPathogens, 10.3390/pathogens11121471, VOL. 11, NO. 12, (1471) Chow P and Kuo H (2022) Performance of urinary biomarkers in differentiating dysfunctional voiding in women with overactive bladder syndrome: a prospective pilot studyInternational Urology and Nephrology, 10.1007/s11255-022-03265-7, VOL. 54, NO. 10, (2497-2502) Ebrahimzadeh T, Kuprasertkul A, Neugent M, Lutz K, Fuentes J, Gadhvi J, Khan F, Zhang C, Sharon B, Orth K, Li Q, Zimmern P and De Nisco N (2021) Urinary prostaglandin E2 as a biomarker for recurrent UTI in postmenopausal womenLife Science Alliance, 10.26508/lsa.202000948, VOL. 4, NO. 7, (e202000948), Online publication date: 1-Jul-2021. Ibrahim O, Basse P, Jiang W, Guru K, Chatta G and Kalinski P (2021) NFκB-Activated COX2/PGE2/EP4 Axis Controls the Magnitude and Selectivity of BCG-Induced Inflammation in Human Bladder Cancer TissuesCancers, 10.3390/cancers13061323, VOL. 13, NO. 6, (1323) Carey M, Vaughn V, Mann J, Townsend W, Chopra V and Patel P (2020) Is Non-Steroidal Anti-Inflammatory Therapy Non-Inferior to Antibiotic Therapy in Uncomplicated Urinary Tract Infections: a Systematic ReviewJournal of General Internal Medicine, 10.1007/s11606-020-05745-x, VOL. 35, NO. 6, (1821-1829), Online publication date: 1-Jun-2020. Al-Maghrabi B, Gomaa W, Abdelwahed M and Al-Maghrabi J (2019) Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor PrognosisAnalytical Cellular Pathology, 10.1155/2019/5026939, VOL. 2019, (1-8), Online publication date: 21-Apr-2019. Sihra N, Goodman A, Zakri R, Sahai A and Malde S (2018) Nonantibiotic prevention and management of recurrent urinary tract infectionNature Reviews Urology, 10.1038/s41585-018-0106-x, VOL. 15, NO. 12, (750-776), Online publication date: 1-Dec-2018. Drake M, Morris N, Apostolidis A, Rahnama'i M and Marchesi J (2017) The urinary microbiome and its contribution to lower urinary tract symptoms; ICI-RS 2015Neurourology and Urodynamics, 10.1002/nau.23006, VOL. 36, NO. 4, (850-853), Online publication date: 1-Apr-2017. Packiriswamy N, Gandy J, Smith S, Mobley H, Sordillo L and Subashchandrabose S (2017) Distinct Signature of Oxylipid Mediators of Inflammation during Infection and Asymptomatic Colonization by E. coli in the Urinary Bladder Mediators of Inflammation, 10.1155/2017/4207928, VOL. 2017, (1-16), . Zacchè M and Giarenis I (2016) Therapies in early development for the treatment of urinary tract inflammationExpert Opinion on Investigational Drugs, 10.1517/13543784.2016.1161024, VOL. 25, NO. 5, (531-540), Online publication date: 3-May-2016. Hughes F, Turner D and Todd Purves J (2015) The potential repertoire of the innate immune system in the bladder: expression of pattern recognition receptors in the rat bladder and a rat urothelial cell line (MYP3 cells)International Urology and Nephrology, 10.1007/s11255-015-1126-6, VOL. 47, NO. 12, (1953-1964), Online publication date: 1-Dec-2015. Nesi G, Nobili S, Cai T, Caini S and Santi R (2015) Chronic inflammation in urothelial bladder cancerVirchows Archiv, 10.1007/s00428-015-1820-x, VOL. 467, NO. 6, (623-633), Online publication date: 1-Dec-2015. Wada N, Ameda K, Furuno T, Okada H, Date I and Kakizaki H (2015) Evaluation of Prostaglandin E2 and E-Series Prostaglandin Receptor in Patients with Interstitial CystitisJournal of Urology, VOL. 193, NO. 6, (1987-1993), Online publication date: 1-Jun-2015. Hannan T, Roberts P, Riehl T, van der Post S, Binkley J, Schwartz D, Miyoshi H, Mack M, Schwendener R, Hooton T, Stappenbeck T, Hansson G, Stenson W, Colonna M, Stapleton A and Hultgren S (2014) Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent CystitisEBioMedicine, 10.1016/j.ebiom.2014.10.011, VOL. 1, NO. 1, (46-57), Online publication date: 1-Nov-2014. Kondo T, Oshima T, Tomita T, Fukui H, Watari J, Okada H, Kikuchi S, Sasako M, Matsumoto T, Knowles C and Miwa H (2013) Prostaglandin E 2 mediates acid-induced heartburn in healthy volunteers American Journal of Physiology-Gastrointestinal and Liver Physiology, 10.1152/ajpgi.00276.2012, VOL. 304, NO. 6, (G568-G573), Online publication date: 15-Mar-2013. Cho K and Kim J (2012) Biomarkers for lower urinary tract dysfunctionInternational Journal of Urology, 10.1111/j.1442-2042.2012.03216.x, VOL. 20, NO. 1, (13-20), Online publication date: 1-Jan-2013. KUO H (2012) Potential Biomarkers Utilized to Define and Manage Overactive Bladder SyndromeLUTS: Lower Urinary Tract Symptoms, 10.1111/j.1757-5672.2011.00131.x, VOL. 4, (32-41), Online publication date: 1-Mar-2012. Zhu Z, Shen Z and Xu C (2012) Inflammatory Pathways as Promising Targets to Increase Chemotherapy Response in Bladder CancerMediators of Inflammation, 10.1155/2012/528690, VOL. 2012, (1-11), . Chen T, Tsai J, Huang H, Teng C, Chien S, Kuo H, Huang W and Chen C (2011) Regulation of cyclooxygenase-2 expression in human bladder epithelial cells infected with type I fimbriated uropathogenic E. coliCellular Microbiology, 10.1111/j.1462-5822.2011.01650.x, VOL. 13, NO. 11, (1703-1713), Online publication date: 1-Nov-2011. Miki T, Matsunami M, Nakamura S, Okada H, Matsuya H and Kawabata A (2011) ONO-8130, a selective prostanoid EP1 receptor antagonist, relieves bladder pain in mice with cyclophosphamide-induced cystitisPain, 10.1016/j.pain.2011.02.019, VOL. 152, NO. 6, (1373-1381), Online publication date: 1-Jun-2011. Liu H, Tyagi P, Chancellor M and Kuo H (2010) Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivityBJU International, 10.1111/j.1464-410X.2009.08851.x, VOL. 106, NO. 11, (1681-1685), Online publication date: 1-Dec-2010. Ratz P, Speich J and Klausner A (2010) COX Inhibitors and Overactive Bladder: The Potential for Future TherapyCurrent Bladder Dysfunction Reports, 10.1007/s11884-009-0037-8, VOL. 5, NO. 1, (4-12), Online publication date: 1-Mar-2010. Oh J, Lee Y, Jin L, Kwon Y, Park W and Lee T (2010) Urodynamic Effects of Propiverine on Detrusor Overactivity and Abdominal Straining during Voiding in Awake Rats with Intravesical Prostaglandin E 2 Instillation Korean Journal of Urology, 10.4111/kju.2010.51.1.64, VOL. 51, NO. 1, (64), . Dovedi S and Davies B (2009) Emerging targeted therapies for bladder cancer: a disease waiting for a drugCancer and Metastasis Reviews, 10.1007/s10555-009-9192-9, VOL. 28, NO. 3-4, Online publication date: 1-Dec-2009. Huang Y, Nikolic D, Pendland S, Doyle B, Locklear T and Mahady G (2009) Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli , COX-2 activity, pro-inflammatory cytokine release and the NF-κβ transcriptional response in vitro Pharmaceutical Biology, 10.1080/13880200802397996, VOL. 47, NO. 1, (18-25), Online publication date: 1-Jan-2009. Wang X, Colby J, Rengel R, Fischer S, Clinton S and Klein R (2009) Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genesMolecular Carcinogenesis, 10.1002/mc.20449, VOL. 48, NO. 1, (1-13), Online publication date: 1-Jan-2009. Rastogi P, Rickard A, Dorokhov N, Klumpp D and McHowat J (2008) Loss of prostaglandin E 2 release from immortalized urothelial cells obtained from interstitial cystitis patient bladders American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00572.2007, VOL. 294, NO. 5, (F1129-F1135), Online publication date: 1-May-2008. Kim O, Jin L, Yoon S and Lee T (2008) The Value and Limitations of Intravesical Prostaglandin E2 (PGE2)-induced Bladder Hyperactivity as an Overactive Bladder Model in Normal, Conscious Sprague-Dawley RatsKorean Journal of Urology, 10.4111/kju.2008.49.6.526, VOL. 49, NO. 6, (526), . Tamarkin F, Kang W, Cohen J, Wheeler M and Weiss R (2006) A role for Akt in the rapid regulation of inflammatory and apoptotic pathways in mouse bladderNaunyn-Schmiedeberg's Archives of Pharmacology, 10.1007/s00210-006-0081-2, VOL. 373, NO. 5, (349-359), Online publication date: 1-Aug-2006. Mokos I, Jakić-Razumović J, Mareković Z and Pasini J (2019) Association of Cyclooxygenase-2 Immunoreactivity with Tumor Recurrence and Disease Progression in Superficial Urothelial Bladder CancerTumori Journal, 10.1177/030089160609200207, VOL. 92, NO. 2, (124-129), Online publication date: 1-Mar-2006. IKEDA M, KAWATANI M, MARUYAMA T and ISHIHAMA H (2006) Prostaglandin facilitates afferent nerve activity via EP1 receptors during urinary bladder inflammation in ratsBiomedical Research, 10.2220/biomedres.27.49, VOL. 27, NO. 2, (49-54), . Yang G, Li L, Ding H and Zhou J (2005) Cyclooxygenase-2 is over-expressed in Chinese esophageal squamous cell carcinoma, and correlated with NF-κB: An immunohistochemical studyExperimental and Molecular Pathology, 10.1016/j.yexmp.2005.09.002, VOL. 79, NO. 3, (214-218), Online publication date: 1-Dec-2005. DOVEDI S, KIRBY J, ATKINS H, DAVIES B and KELLY J (2018) CYCLOOXYGENASE-2 INHIBITION: A POTENTIAL MECHANISM FOR INCREASING THE EFFICACY OF BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR BLADDER CANCERJournal of Urology, VOL. 174, NO. 1, (332-337), Online publication date: 1-Jul-2005. Wadhwa P, Goswami A, Joshi K and Sharma S (2005) Cyclooxygenase-2 Expression Increases with the Stage and Grade in Transitional Cell Carcinoma of the Urinary BladderInternational Urology and Nephrology, 10.1007/s11255-004-4699-z, VOL. 37, NO. 1, (47-53), Online publication date: 1-Mar-2005. SCHRÖDER A, NEWGREEN D and ANDERSSON K (2018) DETRUSOR RESPONSES TO PROSTAGLANDIN E2 AND BLADDER OUTLET OBSTRUCTION IN WILD-TYPE AND EP1 RECEPTOR KNOCKOUT MICEJournal of Urology, VOL. 172, NO. 3, (1166-1170), Online publication date: 1-Sep-2004. Patard J, Rodriguez A and Lobel B (2003) The current status of intravesical therapy for superficial bladder cancerCurrent Opinion in Urology, 10.1097/00042307-200309000-00002, VOL. 13, NO. 5, (357-362), Online publication date: 1-Sep-2003. Sheryka E, Wheeler M, Hausladen D and Weiss R (2003) Urinary interleukin-8 levels are elevated in subjects with transitional cell carcinomaUrology, 10.1016/S0090-4295(03)00134-1, VOL. 62, NO. 1, (162-166), Online publication date: 1-Jul-2003. Volume 168Issue 4 Part 1October 2002Page: 1568-1573 Advertisement Copyright & Permissions© 2002 by American Urological Association, Inc.Keywordsbladderprostaglandin-endoperoxide synthasebladder neoplasmsmycobacterium bovis dinoprostoneMetricsAuthor Information Marcia A. Wheeler More articles by this author Derek A. Hausladen More articles by this author Jeong H. Yoon More articles by this author Robert M. Weiss More articles by this author Expand All Advertisement PDF downloadLoading ...